Renin-angiotensin system blockade and contrast-induced renal toxicity

Journal of Nephrology

Volumn 21, Issue 5, 2008, Pages 681-685

  Saudan, Patrick ^a   Müller, Hajo ^a   Feraille, Eric ^a   Martin, Pierre Yves ^a   Mach, François ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Acute renal failure; Angiotensin II receptor blocker; Angiotensin converting enzyme inhibitor; Contrast nephropathy

Indexed keywords

4 AMINOHIPPURIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; CANDESARTAN; CONTRAST MEDIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EDETATE CHROMIUM CR 51; ENALAPRIL; FOSINOPRIL; HYDROCHLOROTHIAZIDE; INULIN; IOPAMIDOL; IRBESARTAN; LISINOPRIL; LOSARTAN; MERTIATIDE TC 99M; TORASEMIDE;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CHILD; CLINICAL ARTICLE; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY BLOOD FLOW; KIDNEY CLEARANCE; KIDNEY FUNCTION; KIDNEY PLASMA FLOW; MALE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIDE EFFECT; DRUG EFFECT; KIDNEY; KIDNEY SCINTISCANNING; MIDDLE AGED;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; MALE; MIDDLE AGED; RADIOISOTOPE RENOGRAPHY; RENAL BLOOD FLOW, EFFECTIVE;

EID: 63249128923     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Rudnick MR, Berns JS, Cohen RM, Goldfarb S. Contrast media-associated nephrotoxicity. Semin Nephrol. 1997;17:15-26.
2. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med. 1997;103:368-375.
3. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis. 2002;39:930-936.
4. Solomon R. Contrast-medium-induced acute renal failure. Kidney Int. 1998;53:230-242.
5. Norby LH, DiBona GF. The renal vascular effects of meglumine diatrizoate. J Pharmacol Exp Ther. 1975;193:932-940.
6. Brezis M, Greenfeld Z, Shina A, Rosen S. Angiotensin II augments medullary hypoxia and predisposes to acute renal failure. Eur J Clin Invest. 1990;20:199-207.
7. Maeder M, Klein M, Fehr T, Rickli H. Contrast nephropathy: review focusing on prevention. J Am Coll Cardiol. 2004;44:1763-1771.
8. Murphy SW, Barrett BJ, Parfrey PS. Contrast nephropathy. J Am Soc Nephrol. 2000;11:177-182.
9. Buclin T, Sechaud R, Bertschi AP, et al. Estimation of glomerular filtration rate by sinistrin clearance using various approaches. Ren Fail. 1998;20:267-276.
10. Berg UB. Differences in decline in GFR with age between males and females: reference data on clearances of inulin and PAH in potential kidney donors. Nephrol Dial Transplant. 2006;21:2577-2582.
11. Gupta RK, Kapoor A, Tewari S, Sinha N, Sharma RK. Captopril for prevention of contrast-induced nephropathy in diabetic patients: a randomised study. Indian Heart J. 1999;51:521-526.
12. Kini AS, Mitre CA, Kamran M, et al. Changing trends in incidence and predictors of radiographic contrast nephropathy after percutaneous coronary intervention with use of fenoldopam. Am J Cardiol. 2002;89:999-1002.
13. El-Harakeeh MA, Kleiner M, Ahern K, Saggi S. Effects of chronic angiotensin receptor blockers and ACE inhibitors use on the incidence of contrast induces nephropathy in patients with chronic renal insufficiency. J Am Soc Nephrol. 2004;15:347A, SA-PO214.
14. Dangas G, Iakovou I, Nikolsky E, et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol. 2005;95:13-19.
15. Heyman SN, Reichman J, Brezis M. Pathophysiology of radiocontrast nephropathy: a role for medullary hypoxia. Invest Radiol. 1999;34:685-691.
16. Stone GW, McCullough PA, Tumlin JA, et al. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA. 2003;290:2284-2291.
17. Rudnick MR, Goldfarb S, Wexler L, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int. 1995;47:254-261.